Electrocardiogram Devices Market to reach USD 12.2 billion By 2035

The global electrocardiogram devices market was valued at USD 8 billion in 2025 and is expected to grow from USD 8.3 billion in 2026 to USD 12.2 billion in 2035, growing at a CAGR of 4.4% during the forecast period, according to the latest report published by Global Market Insights Inc.

Technological Advancements in ECG Devices

Continuous innovation in electrocardiography technology has significantly enhanced the capabilities of ECG devices, supporting market growth worldwide. Manufacturers have introduced advanced systems featuring improved signal accuracy, faster data processing, wireless connectivity, and integration with digital healthcare platforms. The incorporation of artificial intelligence and advanced analytics has enabled more efficient detection of cardiac abnormalities, allowing healthcare professionals to make quicker and more informed clinical decisions.

Increasing Adoption of Mobile and Telemetry Cardiac Monitors

The growing preference for continuous and remote cardiac monitoring has accelerated the adoption of mobile and telemetry-based cardiac monitoring solutions. Healthcare providers are increasingly utilizing these systems to monitor patients outside traditional clinical settings, enabling real-time tracking of cardiac activity and early identification of potential abnormalities. The increasing prevalence of cardiovascular diseases, coupled with rising demand for personalized and preventive healthcare, has strengthened the need for advanced monitoring technologies.

High Cost of Advanced ECG Devices

The high acquisition and implementation costs associated with advanced ECG devices remain a significant challenge for market growth. Sophisticated systems equipped with advanced software, wireless communication features, artificial intelligence capabilities, and remote monitoring functionalities often require substantial capital investment. In addition to the initial purchase cost, healthcare facilities must also account for expenses related to installation, maintenance, software upgrades, staff training, and system integration.

Browse key industry insights spread across 130 pages with 184 market data tables and figures from the report, Electrocardiogram Devices Market, “By – Product (Diagnostic ECG Machines, Monitoring ECG Devices), By Lead Type (Single Lead Type, 3 Lead Type, 6 Lead Type, 12 Lead Type, Other Lead Types), By Portability (Non-Portable Device, Portable Device), By End Use (Hospitals and Clinics, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings, Other End Users), Growth & Forecast.” in detail, along with the table of contents: https://www.gminsights.com/industry-analysis/electrocardiogram-devices-market

Rising Adoption of Diagnostic ECG Machines

The electrocardiogram devices market from the diagnostics ECG machines segment is projected to grow at a CAGR of 3.8% and is expected to reach USD 6.3 billion by 2035. Growth in this segment is strongly supported by the increasing prevalence of cardiovascular diseases and the rising need for early and accurate cardiac diagnosis across hospitals and diagnostic centers. Diagnostic ECG machines play a vital role in clinical environments by enabling precise monitoring of heart activity and supporting the early detection of serious cardiac conditions.

12-Lead ECG to Gain Traction

The electrocardiogram devices market from the 12-lead ECG segment is expected to grow at a CAGR of 4.8%, reaching USD 5.6 billion by 2035. This segment maintains a leading position due to its superior ability to deliver comprehensive and highly detailed cardiac information, making it the preferred standard for diagnosing complex heart conditions such as myocardial infarction, arrhythmias, and ischemic heart disease. Healthcare professionals widely depend on 12-lead ECG systems for their diagnostic precision and extensive clinical insights, especially in emergency care units and intensive care environments.

U.S. to Emerge as a Propelling Region

U.S. electrocardiogram devices market generated USD 2.5 billion in 2025 and is projected to grow at a CAGR of 3.9% from 2026 to 2035. The expansion is primarily driven by the high incidence of cardiovascular diseases, including heart attacks and arrhythmias, which require continuous monitoring and early diagnosis.

Prominent companies operating in the electrocardiogram devices industry include ALIVECOR, Allengers, Biotricity, Bionet, BIOTRONIK, Boston Scientific, BPL Medical Technologies, CARDIOLINE, FUKUDA, GE HealthCare, Baxter, PHILIPS, Medtronic, Mindray, and SPACELABS HEALTHCARE.

Companies in the electrocardiogram devices market have focused on continuous innovation in product design and digital integration to strengthen their market position. A major strategy includes the development of portable, wearable, and wireless ECG systems that support remote patient monitoring and point-of-care diagnostics. Firms have also increased investment in research and development to enhance diagnostic accuracy through AI-powered analytics and advanced signal processing technologies.

In May 2026, AliveCor received CE Mark approval for its Kardia 12L electrocardiogram system powered by KAI 12L artificial intelligence technology. The company stated that the Kardia 12L was the world’s first artificial intelligence powered portable 12 lead ECG system designed with a single cable configuration for healthcare professionals